Primary Site >> Colorectal Cancer
Gene >> MOS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study. PMID: 6640551 |
Ref: Amplification and elevated expression of c-myc in a chemically induced mouse colon tumor. PMID: 4028026 |
Ref: [Future trends in increasing the efficacy of surgical and combination treatment of cancer of the rectum]. PMID: 2724789 |
Ref: Proto-oncogene allelic variations in human squamous cell carcinomas of the larynx. PMID: 1679639 |
Ref: Low-level c-myc amplification in human colonic carcinoma cell lines and tumors: a frequent, p53-independent mutation associated with improved outcome in a randomized multi-institutional trial. PMID: 9135021 |
Ref: Urethra-sparing cystectomy and orthotopic urinary diversion in women with malignant pelvic tumors. PMID: 11745259 |
Ref: DNA copy number changes at 8q11-24 in metastasized colorectal cancer. PMID: 15750208 |
Ref: [Short-term effects of chemotherapy combined with hydroxycamptothecine and oxaliplatin in treatment of recurrent and metastatic colorectal cancer]. PMID: 16965689 |
Ref: Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer. PMID: 18024868 |
Ref: Third-line therapy for metastatic colorectal cancer. PMID: 17786445 Ref: [Role of cytoreductive surgery in complex treatment for lung metastases from solid tumors]. PMID: 18652241 |
Ref: A nuclear budding mechanism in transiently arrested cells generates drug-sensitive and drug-resistant cells. PMID: 19464429 |
Ref: [The influence of strategy of treatment of obturation colonic tumor obstruction on short-term results and quality of life of patients]. PMID: 21137263 |
Ref: Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer? PMID: 21729677 |
Ref: Analysis of UGT1A1*28 genotype and SN-38 pharmacokinetics for irinotecan-based chemotherapy in patients with advanced colorectal cancer: results from a multicenter, retrospective study in Shanghai. PMID: 23892411 |
Ref: The role of IVS14+1 G > A genotype detection in the dihydropyrimidine dehydrogenase gene and pharmacokinetic monitoring of 5-fluorouracil in the individualized adjustment of 5-fluorouracil for patients with local advanced and metastatic colorectal cancer: PMID: 24817302 Ref: Systemic inflammation, as measured by the neutrophil/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patients. PMID: 25148896 Ref: PCR-based assays versus direct sequencing for evaluating the effect of KRAS status on anti-EGFR treatment response in colorectal cancer patients: a systematic review and meta-analysis. PMID: 25260023 |
Ref: P62/Ubiquitin IHC Expression Correlated with Clinicopathologic Parameters and Outcome in Gastrointestinal Carcinomas. PMID: 25870850 Ref: Activation of 5-HT4 receptors facilitates neurogenesis of injured enteric neurons at an anastomosis in the lower gut. PMID: 26658112 |
Ref: Surgical Resection Preferences and Perceptions among Medical Oncologists Treating Liver Metastases from Colorectal Cancer. PMID: 26561404 Ref: BRAF Mutation Testing and Metastatic Colorectal Cancer in the Community Setting: Is There an Urgent Need for More Education? PMID: 26714964 Ref: Benchmarking trial between France and Australia comparing management of primary rectal cancer beyond TME and locally recurrent rectal cancer (PelviCare Trial): rationale and design. PMID: 27044252 Ref: Treatment of Metastatic Colorectal Cancer Patients >/=75 Years Old in Clinical Practice: A Multicenter Analysis. PMID: 27442239 Ref: Vorinostat and hydroxychloroquine improve immunity and inhibit autophagy in metastatic colorectal cancer. PMID: 27463016 |
Ref: Social support following diagnosis and treatment for colorectal cancer and associations with health-related quality of life: Results from the UK ColoREctal Wellbeing (CREW) cohort study. PMID: 29094430 |
Ref: Left Versus Right: Does Location Matter for Refractory Metastatic Colorectal Cancer Patients in Phase 1 Clinical Trials? PMID: 28432610 Ref: Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients bearing MGMT methylation. PMID: 29860358 Ref: Brain metastases in colorectal cancer: prognostic factors and survival analysis. PMID: 29943356 Ref: FGFR3 mRNA overexpression defines a subset of oligometastatic colorectal cancers with worse prognosis. PMID: 30181810 Ref: Data on tumor progression of c-mos deficiency in murine models of Kras(G12D) lung and Apc(Min) colorectal cancer. PMID: 30229128 |